Colon News and Research

RSS

ASIR can reduce radiation dose associated with abdominal CT scans: Study

A new low-dose abdominal computed tomography (CT) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with abdominal CT scans by 23-66 percent, according to a study in the September issue of the American Journal of Roentgenology.

21 Aug 2010

CRC imaging technique identifies early extracolonic lesions of colorectal cancer

Although the medical community has already accepted that colorectal cancer (CRC) screening is cost effective and saves lives, researchers have found that computed tomography colonography (CTC or virtual colonoscopy) not only identifies CRC but also doubles the yield of identifying significant early extracolonic (outside the colon) lesions, resulting in lives saved.

21 Aug 2010

Cancer patients may live longer with palliative and hospice care services: Study

A new study released by the New England Journal of Medicine found that among patients with non-small-cell lung cancer, those who received palliative care lived, on average, almost two months longer than those who received standard care. Researchers also found that the patients receiving palliative care reported a higher quality of life through the final course of their illness.

20 Aug 2010

Stand Up To Cancer prepares for next Team Fundraising Challenge

As part of a new long-term alliance, Stand Up To Cancer is gearing up for its next Team Fundraising Challenge by joining forces with one of television's most popular shows, Survivor on CBS. For the first time ever, Survivor will stand up and issue the "Challenge The Odds" Team Challenge with Stand Up To Cancer Ambassador and winner of Survivor: Africa, Ethan Zohn.

18 Aug 2010

FDA considers dropping Avastin approval, approves five-day emergency contraception pill

The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.

17 Aug 2010

Susan G. Komen for the Cure, OCNA urge FDA to allow use of Avastin

Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.

13 Aug 2010

LCA launches “National Shine a Light on Lung Cancer Vigil” to raise awareness

Today, Lung Cancer Alliance (LCA) announced the launch of the National Shine a Light on Lung Cancer Vigil to honor loved ones, raise awareness and provide hope, compassion and support for all those touched by lung cancer.

12 Aug 2010

Viatronix releases latest version of V3D-Colon software with FDA 510(k) approved colon CAD

Viatronix Incorporated, a Stony Brook, New York, based company announced the release of the latest version of its leading edge V3D-Colon software with the option to have the industry's first FDA 510(k) approved colon CAD, VeraLook™ by iCAD.

12 Aug 2010

K-State researcher receives grant from NIH to continue cancer research

Understanding how cancer cells communicate with each other and how to enhance their receptiveness to drug treatments is the focus of promising work by a Kansas State University researcher.Annelise Nguyen, assistant professor of toxicology in the department of diagnostic medicine and pathobiology at K-State's College of Veterinary Medicine, recently received a $370,000 grant from the National Institutes of Health to continue her cancer research.

12 Aug 2010

Third round of tax-free $250 rebate checks mailed to eligible Medicare beneficiaries

Today, U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced that the third round of one-time, tax-free $250 rebate checks have been mailed to eligible Medicare beneficiaries whose drug costs are so high they have reached the Medicare Part D prescription drug coverage gap known as the "donut hole."

11 Aug 2010

SMI/Omega development team receives fund to develop prototype fast multispectral endoscope

Cascade Technologies, Inc., announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will receive NIH research funding through a collaboration with Omega Optical of Brattleboro, Vermont. This effort will accelerate development of a new class of medical endoscopes enhanced with proprietary multispectral imaging technology. The principal investigators on the project are Dr. Gary Carver, Director of Research at Omega Optical, and Dr. Daniel L. Farkas, Chairman and CEO of SMI.

11 Aug 2010

Study results provide rationale for use of PI3K inhibitors in therapeutic settings

Research at the Babraham Institute, investigating how white blood cells known as B cells develop, has revealed that genes from the Phosphatidylinositol 3-kinase family of enzymes are critical in enabling the B cells to produce antibodies in the spleen and lymph nodes.

10 Aug 2010

Epitherix identifies potent and selective multiple chemical scaffolds against colorectal carcinoma

Epitherix, LLC, a privately held company focused on the discovery and development of novel Wnt pathway small molecule inhibitors for epithelial and leukemic cancers, today announced that it has identified multiple chemical scaffolds that are potent and selective against colorectal carcinoma. "We're very encouraged by our in vitro and in vivo data, especially considering the difficulty in drugging this pathway to date," said Dr. Osman Kibar, CEO of Epitherix.

10 Aug 2010

Funk Out Cancer to raise money, awareness for research at University of Wisconsin

Funk Out Cancer is back for the second annual concert and silent auction to raise money and awareness for cancer research at the University of Wisconsin Carbone Cancer Center. Funk Out Cancer will feature music by international recording artists funk/jazz trio SOULIVE along with special guests Madison's own Phat Phunktion and Mama Digdown's Brass Band. The event will be held on Saturday, November 20 at 7:00 PM at the Orpheum Theatre, Madison.

7 Aug 2010

Split-dosage method effective for bowel cleansing before colonoscopy: Study

A new study from researchers in Italy has found that a split-dosage schedule of bowel (colon) preparation is the most effective method for bowel cleansing before colonoscopy. Colonoscopies performed within six to eight hours of the end of preparation were associated with significantly better cleansing than those performed more than eight hours after the end of preparation. Two different types of bowel cleansing products were also assessed and researchers found that low-volume polyethylene glycol (PEG) plus ascorbic acid was as effective as high-volume PEG-electrolyte solution, but has superior palatability (or taste). This is the first study to demonstrate that the advantage of split-dosage intake is also true for low-volume bowel cleansing solutions.

6 Aug 2010

Scientists suggest home genetic tests may cause unnecessary stress

In the age of the Internet, where cybercondriacs are just a mouse click away from a diagnosis, do-it-yourself home genetics test may seem like the next logical step in managing health. But these tests, which are relatively new and available online, are often not comprehensive and may cause unnecessary stress, warns Suzanne Mahon, DNSc., a clinical professor of hematology and oncology at Saint Louis University.

5 Aug 2010

FDA clears iCAD's VeraLook computer-aided detection product for virtual colonoscopy

The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.

5 Aug 2010

BCM collaborates with Roche NimbleGen for high throughput exome capture technology

The Baylor College of Medicine Human Genome Sequencing Center has standardized its target enrichment human disease research studies on Roche NimbleGen Sequence Capture Exome technology. The Baylor HGSC will sequence over 5,000 exomes in the next two years to identify genetic variants underlying multiple human diseases and will employ NimbleGen SeqCap EZ Exome and customized NimbleGen exome designs as the exome capture technology of choice. More than 15 different diseases will be investigated by Baylor HGSC, including brain, liver, pancreatic, colon, ovarian and bladder cancers, heart disease, diabetes, autism, and other inherited diseases with the goal of better understanding causative mutations and their impact on these diseases.

4 Aug 2010

Long term decline in hemoglobin may announce onset of colorectal cancer

Anemia, a common blood disorder characterized by low hemoglobin levels, has long been associated with those suffering from colorectal cancer. But researchers at Tel Aviv University have discovered that, more than a symptom of active disease, low hemoglobin levels can actually indicate a potential for colon cancer years before it's diagnosed.

4 Aug 2010

Study explores role of genetic influence on ulcerative colitis

Adults diagnosed with ulcerative colitis after age 50 are more likely to achieve remission from their symptoms than patients diagnosed at younger ages, even when those patients receive similar treatments, according to research at Washington University School of Medicine in St. Louis.

3 Aug 2010

Colon News and Research

ASIR can reduce radiation dose associated with abdominal CT scans: Study

CRC imaging technique identifies early extracolonic lesions of colorectal cancer

Cancer patients may live longer with palliative and hospice care services: Study

Stand Up To Cancer prepares for next Team Fundraising Challenge

FDA considers dropping Avastin approval, approves five-day emergency contraception pill

Susan G. Komen for the Cure, OCNA urge FDA to allow use of Avastin

LCA launches “National Shine a Light on Lung Cancer Vigil” to raise awareness

Viatronix releases latest version of V3D-Colon software with FDA 510(k) approved colon CAD

K-State researcher receives grant from NIH to continue cancer research

Third round of tax-free $250 rebate checks mailed to eligible Medicare beneficiaries

SMI/Omega development team receives fund to develop prototype fast multispectral endoscope

Study results provide rationale for use of PI3K inhibitors in therapeutic settings

Epitherix identifies potent and selective multiple chemical scaffolds against colorectal carcinoma

Funk Out Cancer to raise money, awareness for research at University of Wisconsin

Split-dosage method effective for bowel cleansing before colonoscopy: Study

Scientists suggest home genetic tests may cause unnecessary stress

FDA clears iCAD's VeraLook computer-aided detection product for virtual colonoscopy

BCM collaborates with Roche NimbleGen for high throughput exome capture technology

Long term decline in hemoglobin may announce onset of colorectal cancer

Study explores role of genetic influence on ulcerative colitis

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News